Replimune Group
REPL· Manufacturing· Fiscal year ends in March
CEO pay in FY2025Stock +19.3% in FY2025
Sushil Patel is the CEO of Replimune Group and was paid $3.7M in FY2025 (Mar), up 79%.
Pay$100 in the stock at the end of FY23 → $55
Executives3
See all- 1Sushil PatelChief Executive OfficerFY2025
- 2Konstantinos XynosChief Medical OfficerFY2025
- 3Emily HillChief Financial OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allReplimune Group paid its 3 named executives $6.9M in total in FY2025 (Mar). CEO Sushil Patel was paid $3.7M of that.
| Name | |||
|---|---|---|---|
| Sushil PatelChief Executive Officer | Not disclosed | ||
| Konstantinos XynosChief Medical Officer | |||
| Emily HillChief Financial Officer |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Replimune Group. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board2
See all- Kapil Dhingra, M.B.B.S.Director · 4 yr on the boardIndependentCompensation, Research & Development (Chair)—Paid as an executive
- Michael GollerDirector · 0 yr on the boardIndependentNominating and Corporate Governance (Chair)—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | Jul 25, 2025 | FY2025 |
| Annual report | 10-K | May 22, 2025 | FY2025 |
| Proxy statement | DEF 14A | Jul 19, 2024 | FY2024 |
| Annual report | 10-K | May 16, 2024 | FY2024 |
| Proxy statement | DEF 14A | Jul 26, 2023 | FY2023 |
| Annual report | 10-K | May 18, 2023 | FY2023 |